Revenue trends, scenario modelling, valuation context, and side-by-side comparisons help growth investors pressure-test a thesis without building spreadsheet workflows from scratch.
No credit card required
Growth investors need to track revenue trends, unit economics, and scalability while stress-testing assumptions. Spreadsheets and static screens make it hard to model scenarios and compare growth rates across a universe of names.
Chartloom supports growth-oriented research with revenue and growth-rate charts, a Scenario Lab for adjusting assumptions, and comparison tools. AI SEC summaries highlight business model and competitive positioning. Investors can visualise trends and run scenarios before deepening research.
Stress-test investment theses by adjusting revenue growth, margins, and earnings assumptions. See how valuation and estimates change under different scenarios.
Learn moreVisualise revenue growth, YoY rates, and historical trends over 35+ years. Compare growth rates across companies and sectors.
Learn moreQuick overview of business model, competitive moat, and risk factors. Useful for screening and prioritising deeper dives into growth stories.
Learn moreCompare key metrics and charts across multiple tickers side by side. Helps identify relative strength and growth profiles.
Learn moreEV/Sales, P/S, and growth-adjusted metrics in one place. Track how the market is pricing growth over time.
Learn moreMargin trends, cash flow, and capital efficiency charts. Export for research notes and sharing.
Learn moreScenario modelling, long-term revenue charts, and comparison workflows designed for testing growth narratives.

10-K & 10-Q filings distilled into concise summaries in seconds.

Stress-test company theses with adjustable assumptions and instant outcome updates.

Visualise 35+ years of fundamentals. Export-ready for X, Substack, and LinkedIn.

Rank stocks by any metric and share your research with the community.

Drag-and-drop widgets make it easy to build a tailored research view.

Study full business cycles. Most platforms limit data to 10 years.

Side-by-side analysis across 50+ valuation metrics in one view.

Track holdings, dividends, and dollar-cost averaging performance.

70+ financial metrics explained with real examples and context.
At $10/month with a 14-day free trial, Chartloom offers scenario modelling and growth-focused charts at a fraction of the cost of premium terminals. Growth investors may find it useful for screening and thesis testing.
$10/mo
Free trial included; all features unlocked
AI-powered SEC summaries, 100+ interactive charts, and the Scenario Lab. Free trial; no credit card required.